TNF and rheumatoid arthritis: Baseline PD scores were able to predict responders vs non-responders to TNF inhibitors at 3 months in seropositive RA patients, while baseline clinical features were not (DAS28).Non-responder patients have excess inflammatory activity that is detectable with PDUS but not with clinical examination